Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and folic acid

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with folic acid in 1 studies

Compound Research Comparison

Studies
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)
Trials
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)
Recent Studies (post-2010)
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)
Studies
(folic acid)
Trials
(folic acid)
Recent Studies (post-2010) (folic acid)
6383124330,0011,94510,195

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bell, JD; Bunch, J; Jorgensen, MR; Kalber, TL; Kamaly, N; McLeod, CW; Miller, AD; Pugh, JA; So, PW1

Other Studies

1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and folic acid

ArticleYear
A low molecular weight folate receptor targeted contrast agent for magnetic resonance tumor imaging.
    Molecular imaging and biology, 2011, Volume: 13, Issue:4

    Topics: Animals; Cell Line, Tumor; Contrast Media; Folate Receptors, GPI-Anchored; Folic Acid; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Mice; Mice, Nude; Molecular Weight; Organometallic Compounds; Spectrophotometry, Atomic; Staining and Labeling

2011